Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: Selective augmentation of peptide-presenting dendritic cells in nasal mucosa-associated lymphoid tissue

Infection and Immunity

Volumn 66, Issue 12, 1998, Pages 5876-5881

  Porgador, Angel ^a,b   Staats, Herman F ^c   Itoh, Yasushi ^a   Kelsall, Brian L ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; EPITOPE; IMMUNOLOGICAL ADJUVANT;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEMALE; IMMUNIZATION; LYMPHOID TISSUE; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL;

EID: 0031741198     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.12.5876-5881.1998     Document Type: Article

References (56)

1. Bergerot, I., C. Ploix, J. Petersen, V. Moulin, C. Rask, N. Fabien, M. Lindblad, A. Mayer, C. Czerkinsky, J. Holmgren, and C. Thivolet. 1997. A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc. Natl. Acad. Sci. USA 94:4610-4614.
2. Bowen, J. C., S. K. Nair, R. Reddy, and B. T. Rouse. 1994. Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens. Immunology 81:338-342.
3. Bromander, A., J. Holmgren, and N. Lycke. 1991. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J. Immunol. 146:2908-2914.
4. Bromander, A. K., M. Kjerrulf, J. Holmgren, and N. Lycke. 1993. Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells. Scand. J. Immunol. 37:452-458.
5. Chen, Y., J. Inobe, R. Marks, P. Gonnella, V. K. Kuchroo, and H. L. Weiner. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177-180. (Erratum, 21:377.)
6. Cong, Y., C. T. Weaver, and C. O. Elson. 1997. The mucosal adjuvanicity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression. J. Immunol. 159:5301-5308.
7. Cumberbatch, M., R. J. Dearman, and I. Kimber. 1997. Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology 92:388-395.
8. Dick, A. D., Y. F. Cheng, A. McKinnon, J. Liversidge, and J. V. Forrester. 1993. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Br. J. Ophthalmol. 77:171-175.
9. Dickinson, B. L., and J. D. Clements. 1995. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 63:1617-1623.
10. b recognition, J. Immunol. 152:1790-1801.
11. Elson, C. O. 1996. Cholera toxin as a mucosal adjuvant, p. 59-65. In H. Kiyono, P. L. Ogra, and J. R. McGhee (ed.), Mucosal vaccines. Academic Press, New York, N.Y.
12. Elson, C. O., and M. T. Dertzbaugh. 1994. Mucosal adjuvants, p. 391-402. In P. L. Ogra et al. (ed.), Handbook of mucosal immunology. Academic Press, San Diego, Calif.
13. Finkelman, F. D., A. Lees, R. Birnbaum, W. C. Gause, and S. C. Morris. 1996. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 157:1406-1414.
14. Galkowska, H., U. Wojewodzka, and W. L. Olszewski. 1995. Cytokines and adherence molecules involved in spontaneous dendritic cell-lymphocyte clusterine in skin afferent lymph. Scand. J. Immunol. 42:324-330.
15. Hoyne, G. F., R. E. O'Hehir, D. C. Wraith, W. R. Thomas, and J. R. J. R. Lamb. 1993. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J. Exp. Med. 178:1783-1788.
16. Husby, S., J. Mestecky, Z. Moldoveanu, S. Holland, and C. O. Elson. 1994. Oral tolerance in humans: T cell but not B cell tolerance after antigen feeding. J. Immunol. 152:4663-4670.
17. Inaba, K., J. D. Metlay, M. T. Crowley, and R. M. Steinman. 1990. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172:631-640.
18. Joseph, S. B., K. T. Miner, and M. Croft. 1998. Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF. Eur. J. Immunol. 28:277-289.
19. Karttunen, J., S. Sanderson, and S. Shastri. 1992. Detection of rare antigen-presenting cells by the LacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. USA 89:6020-6024.
20. Knight, S. C., and A. J. Stagg. 1993. Antigen-presenting cell types. Curr. Opin. Immunol. 5:374-382.
21. Kuper, C. F., P. J. Koornstra, D. M. H. Hameleers, J. Biewenga, B. J. Spit, A. M. Duijvestijn, P. J. C. van Breda Vriesman, and T. Sminia. 1992. The role of nasopharyngeal lymphoid tissue. Immunol. Today 13:219-224.
22. Lycke, N., T. Tsuji, and J. Holmgren. 1992. The adjuvant effect of Vibrio cholerae and Escherichia coli heat labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 22:2277-2281.
23. Lycke, N., A. K. Bromander, L. Ekman, U. Karlsson, and J. Holmgren. 1989. Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo. J. Immunol. 142:20-27.
24. Lycke, N., and N. Holmgren. 1986. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59:301-308.
25. Lycke, N., U. Karlsson, A. Sjolander, and K. E. Magnusson. 1991. The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand. J. Immunol. 33:691-698.
26. Lycke, N., and W. Strober. 1989. Cholera toxin promotes B cell isotype differentiation. J. Immunol. 142:3781-3787.
27. Macatonia, S. E., S. C. Knight, A. J. Edwards, S. Griffiths, and P. Fryer. 1987. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies. J. Exp. Med. 166:1654-1667.
28. Macatonia, S. E., P. M. Taylor, S. C. Knight, and B. A. Askonas. 1989. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T-cell responses in vitro. J. Exp. Med. 1255-1264.
29. McWilliam, A. S., S. Napoli, A. M. Marsh, F. L. Pemper, D. J. Nelson, C. L. Pimm, P. A. Stumbles, T. N. Wells, and P. G. Holt. 1996. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J. Exp. Med. 184:2429-2432.
30. McWilliam, A. S., D. Nelson, J. A. Thomas, and P. G. Holt. 1994. Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J. Exp. Med. 179:1331-1336.
31. Metzler, B., and D. C. Wraith. 1993. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5:1159-1165.
32. Mowat, A. M. 1994. Oral tolerance and regulation of immunity to dietary antigens, p. 185-201. In P. L. Ogra et al. (ed.), Handbook of mucosal immunology. Academic Press, San Diego, Calif.
33. Ozawa, H., S. Nakagawa, H. Tagami, and S. Aiba. 1996. Interleukin-1 beta and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently. J. Investig. Dermatol. 106:441-445.
34. Porgador, A., H. F. Staats, B. Faiola, E. Gilboa, and T. J. Palker. 1997. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo. J. Immunol. 158:834-841.
35. Prakken, B. J., R. van der Zee, S. M. Anderton, P. J. S. van Kooten, W. Kuis, and W. V. Eden. 1997. Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc. Natl. Acad. Sci. USA 94:3284-3289.
36. Roake, J. A., A. S. Rao, P. J. Morris, C. P. Larsen, D. F. Hankins, and J. M. Austyn. 1995. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 181:2237-2247.
37. + T cell repertoire that displays both diversity and peptide specificity. Eur. J. Immunol. 26:288-293.
38. Sanderson, I. A., and W. A. Walker. 1994. Mucosal barrier, p. 41-31. In P. L. Ogra et al. (ed.), Handbook of mucosal immunology. Academic Press, San Diego, Calif.
39. Schuler, G., B. Thurner, and N. Romani. 1997. Dendritic cells: from ignored cells to major players in T-cell-mediated immunity. Int. Arch. Allergy Immunol. 112:317-322.
40. Shankar, G., E. S. Pickard, and K. Burnham. 1996. Superantigen-induced Langerhans cell depletion is mediated by epidermal cell-derived IL-1 alpha and TNF alpha. Cell. Immunol. 171:240-245.
41. Shibuya, K., D. Robinson, F. Zonin, S. B. Hartley, S. E. Macatonia, C. Somoza, C. A. Hunter, K. M. Murphy, and A. O'Garra. 1998. IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. J. Immunol. 160:1708-1716.
42. Shirai, M., D. Pendleton, J. Ahlers, T. Takeshita, M. Newman, and J. A. Berzofsky. 1994. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. J. Immunol. 152:549-556.
43. Staats, H. F., S. P. Montgomery, and T. J. Palker. 1997. Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses. AIDS Res. Hum. Retroviruses 13:945-952.
44. Staats, H. F., W. G. Nichols, and T. J. Palker. 1996. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J. Immunol. 157:462-472.
45. Staines, N. A., N. Harper, F. J. Ward, V. Malmstrom, R. Holmdahl, and S. Bansal. 1996. Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal administration of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin. Exp. Immunol. 103:368-375.
46. Steinbrink, K., M. Wolfl, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772-4780.
47. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271-296.
48. Steinman, R. M., M. Pack, and K. Inaba. 1997. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 156:25-37.
49. Sun, J. B., C. Rask, T. Olsson, J. Holmgren, and C. Czerkinsky. 1996. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc. Natl. Acad. Sci. USA 93:7196-7201.
50. Suss, S., and K. Shortman. 1996. A subclass of dendritic cells kills CD4 T cells via fas/fas-ligand-induced apoptosis. J. Exp. Med. 183:1789-1796.
51. Swiggard, W., M. D. Noncas, M. D. Witmer-Pack, and R. M. Steinman. 1991. Enrichment of dendritic cells by plastic adherence and EA rosetting, p. 3.7.1-3.7.11. In J. E. Coligan et al. (ed.), Current protocols in immunology. John Wiley & Sons, Inc., New York, N.Y.
52. Tian, J., M. A. Atkinson, M. Clare-Salzler, A. Herschenfeld, T. Forsthuber, P. V. Lehmann, and D. L. Kaufman. 1996. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:1561-1567.
53. Woogen, S. D., W. Ealding, and C. O. Elson. 1987. Inhibition of murine lymphocyte proliferation by the B subunit of cholera toxin, J. Immunol. 139:3764-3770.
54. Wu, H.-Y., H. H. Nguyen, and M. W. Russell. 1997. Nasal lymphoid tissue (NALT) as a mucosal inductive site. Scand. J. Immunol. 46:506-513.
55. Xu-Amano, J., H. Kioyno, R. L. Jackson, H. F. Staats, K. Fujihashi, P. D. Burrows, C. O. Elson, S. Pillai, and J. R. McGhee. 1993. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178:1309-1320.
56. Yamamoto, S., H. Kiyono, M. Yamamoto, K. Imaoka, K. Fujihashi, F. W. Van Ginkel, M. Noda, Y. Takeda, and J. R. McGhee. 1997. A nontoxic mutant of cholera toxin elicits TH2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. USA 94:5267-5272.